GLOOM
-
Anxiety, AUROC, Brain, calibration, ENIGMA-OCD, neuroimaging biomarkers, neuroscience, OCD clinical AI, Psychiatry, resting-state fMRI, site generalization, transformer modelOCD Clinical AI Reached AUROC 0.653 but Failed Site Generalization
A 2026 ENIGMA-OCD preprint tested a transformer model on resting-state fMRI from…
-
aggression, antipsychotics, bdnf, cognition, inflammation, left DLPFC, Neurostimulation, randomized trial, risperidone, rtms, schizophreniarTMS Plus Risperidone Improved Schizophrenia Cognition
A 2026 randomized study involving 80 people with schizophrenia found that adding…
-
Anxiety, anxiety symptoms, CBT app, depression, depression symptoms, digital mental health, executive function training, Psychology, randomized controlled trial, therapy, workplace wellbeingWorkplace Mental Health Apps Split Outcomes: Anxiety Down, Wellbeing Up
A 228-person randomized trial found a split result for workplace mental-health apps:…
-
caffeine, circadian rhythm, dopamine, Drosophila, Drugs, impulsivity, inhibitory control, motor behavior, mushroom body, neuroscience, nighttime caffeine, shift work, sleepNighttime Caffeine Increased Impulsivity Through Dopamine in Fly Study
A 2025 iScience study found that nighttime caffeine increased motor impulsivity in…
-
behavioral activation, cognitive behavioral therapy, depression, depression remission, exercise priming, major depressive disorder, pilot randomized trial, Psychology, therapeutic alliance, therapyExercise Before CBT Raised Depression Remission to 69% in Pilot Trial
A 40-person pilot trial found depression remission in 69% of adults who…
-
cognitive impairment, depression, depression genetics, endothelial dysfunction, first-episode depression, genetics, geriatric depression, inflammatory markers, MMSE, neuroscience, nitric oxide synthase, NOS3, Psychiatry, rs1799983NOS3 TT Variant Linked to 1.72x Cognitive Risk in First-Episode Depression
A 2026 cross-sectional study of 519 older adults with first-episode depression found…
-
anti-CD20 therapy, Brain, cladribine, Delphi consensus, disease modifying therapy, high efficacy DMTs, multiple sclerosis, Neurodegenerative Diseases, neurology, neuroscience, patient involvement, personalized therapy, treatment adherenceMultiple Sclerosis Personalized Therapy: 70% Delphi Consensus
An Italian multiple sclerosis Delphi panel reached consensus on 116 of 166…
-
Brain, brain development, CA3, cognition, hippocampus, memory circuits, neuroscience, patch clamp, pattern completion, pyramidal neurons, synaptic connectivityCA3 Memory Circuit Connectivity Falls From 6.37% to 2.17%
A 2026 Nature Communications mouse study tested 7,736 possible connections in the…
-
alpha-synuclein, Alzheimer’s disease, blood brain barrier, Brain, microplastics, Neurodegenerative Diseases, neuroinflammation, neuroscience, oxidative stress, parkinson’s diseaseMicroplastics and Parkinson’s Disease: 6 Plausible Brain-Risk Pathways
A 2026 mechanistic review linked microplastics to 6 proposed Alzheimer’s disease pathways…
-
auditory brainstem response, Brain, central sensitization, cochlea, early life stress, gut-inner ear axis, IBS, neuroscience, proteomics, rat model, sensory processing, Stress, visceral stressEarly-Life Visceral Stress Sensitized Auditory Brainstem Responses in Rats
A 40-rat early-life visceral stress study found auditory pathway sensitization without hearing-threshold…
